Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Diasol Inc
WARNING LETTER
•Diasol Inc•May 28, 2010

Diasol Inc – FDA Warning Letter, May 28, 2010

Record Details

On August 9, 2010, the FDA issued a Warning Letter to Diasol, Inc. following inspections at their San Fernando, CA (May 19-28, 2010) and Phoenix, AZ (January 1-February 3, 2010) manufacturing sites. The inspections revealed that Diasol, Inc. manufactures liquid and dry hemodialysis concentrates, classified as adulterated devices under section 501(h) of the Act, due to non-conformity with Current Good Manufacturing Practice (CGMP) requirements of the Quality System (QS) regulation (21 CFR Part 820).

Key violations include: 1. Failure to validate processes where results cannot be fully verified by subsequent inspection and test (21 CFR 820.75(a)), specifically incomplete cleaning validation for liquid dialysis concentrate containers. 2. Failure to establish and maintain acceptance procedures for in-process products (21 CFR 820.80(c)), observed in water testing procedures. 3. Failure to document all Corrective and Preventative Action (CAPA) activities and results (21 CFR 820.100), as a CAPA log was not maintained. 4. Failure to investigate nonconformities to determine the cause (21 CFR 820.100(a)(2)), specifically an uninvest

Company
Diasol Inc
Inspection date
May 28, 2010
Product type
Devices
Office
Los Angeles District Office
People
  • Marco S. Esteves
  • Alonza E. Cruse (Director)
View Company Profile

ID · 4b11c140-6b32-4b6d-8f64-1ff471a38a34

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.75(a)21 CFR 820.80(c)21 CFR 820.10021 CFR 820.100(a)(2)21 CFR 820.184(a)21 CFR 820.18421 CFR 820.72(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Diasol Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.